GREBT’s in-vitro diagnostic device, URINOUGH, is a compact diagnostic system based
on electrochemical analysis technology. It is designed for general users to directly monitor diseases
or specific biomarkers on their own.
The current in-vitro diagnostic configuration includes a urine glucose meter
and urine glucose test strips, enabling users to continuously and repeatedly measure glucose levels through urine.
Technical principle
Bio-Electronic Sensor Detectable
Through Urine
Based on our patented technology, the urine-detectable bio-electronic sensor enables glucose measurement without blood sampling. Our optimized portable urine glucose sensor quantifies glucose levels directly from urine, allowing the mobile app to analyze pre-meal, post-meal, daily, weekly, and monthly data. Through real-time monitoring, it supports effective diabetes management.
Additionally, the compact portable urine glucose sensor can be linked with smartphones, wearable devices, or clinical systems to upload data in real time. This technology can be applied not only to urine glucose measurement, but also to detecting various biomarkers in urine—such as vitamins, blood, and ketone bodies.
Features
Pain-Free Testing
Anyone can measure glucose levels
without the pain of pricking
multiple fingers with a lancet.
Easy Portability
The device consists only of the
meter and strip, making it easy to
carry anywhere.
User Convenience
There’s no need for the
complicated steps of disinfecting,
drawing blood.
Cost-Effective Use
With advanced sensor technology,
it can be rinsed and reused—up to
50 times per strip.